Regeneron On Pace for Largest Percent Decrease Since November 2021 -- Data Talk

Regeneron Pharmaceuticals, Inc. (REGN) is currently at $628.00, down $30.92 or 4.69%

--Would be lowest close since May 11, 2022, when it closed at $613.05

--On pace for largest percent decrease since Nov. 5, 2021, when it fell 5.57%

--Currently down four of the past five days

--Currently down three consecutive days; down 9.35% over this period

--Worst three day stretch since the three days ending March 20, 2020, when it fell 10.83%

--Down 0.56% year-to-date

--Down 15% from its all-time closing high of $738.84 on April 8, 2022

--Up 24.19% from 52 weeks ago (June 3, 2021), when it closed at $505.66

--Down 15% from its 52-week closing high of $738.84 on April 8, 2022

--Up 24.19% from its 52-week closing low of $505.66 on June 3, 2021

--Traded as low as $617.21; lowest intraday level since May 12, 2022, when it hit $606.77

--Down 6.33% at today's intraday low; largest intraday percent decrease since Nov. 5, 2021, when it fell as much as 8.2%

--Fifth worst performer in the S&P 500 today

--Third worst performer in the Nasdaq 100 today

All data as of 11:04:38 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

June 02, 2022 11:22 ET (15:22 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.